JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2008; 52:13-16, doi:10.1016/j.jacc.2008.03.037
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Beohar, N.
Right arrow Articles by Gheorghiade, M.
PubMed
Right arrow Articles by Beohar, N.
Right arrow Articles by Gheorghiade, M.
Related Collections
Right arrowRelated Article

VIEWPOINT

Acute Heart Failure Syndromes and Coronary Perfusion

Nirat Beohar, MD, FACC*,*, Ata K. Erdogan, MD*, Daniel C. Lee, MD*, Hani N. Sabbah, PhD, FACC{dagger}, Morton J. Kern, MD, FACC{ddagger}, John Teerlink, MD, FACC§, Robert O. Bonow, MD, FACC* and Mihai Gheorghiade, MD, FACC*

* Feinberg School of Medicine, Northwestern University, Chicago, Illinois
{dagger} Henry Ford Health System, Detroit, Michigan
{ddagger} University of California, Irvine, California
§ University of California, San Francisco, California.

Manuscript received January 28, 2008; revised manuscript received March 18, 2008, accepted March 24, 2008.

* Reprint requests and correspondence: Dr. Nirat Beohar, Bluhm Cardiovascular Institute, Feinberg School of Medicine, 8-790A Feinberg Pavilion, 251 East Huron Street, Northwestern Memorial Hospital, Chicago, Illinois 60611. (Email: n-beohar{at}northwestern.edu).

Acute heart failure syndromes (AHFS), with a high post-discharge mortality and rehospitalization rate, represent a significant public health burden. The treatment of patients hospitalized with AHFS often includes the use of vasoactive medications such as inotropes and vasodilators. Although such agents are frequently used, their safety and efficacy remain controversial. A significant number of patients with heart failure have underlying coronary artery disease and may be at greater risk from hemodynamic alterations that can diminish coronary perfusion. In AHFS, the relationship among vasoactive medications, coronary perfusion, and potential myocardial injury needs further investigation. Newer techniques now available to evaluate coronary perfusion should provide guidance for the evaluation of existing and future vasoactive therapies for AHFS.

Key Words: acute heart failure syndromes • coronary artery disease • coronary perfusion • microcirculation

Abbreviations and Acronyms
  AHFS = acute heart failure syndromes
  CAD = coronary artery disease
  CFR = coronary flow reserve
  FFR = fractional flow reserve
  HSR = hyperemic stenosis resistance
  IMR = index of microcirculatory resistance
  rCFR = relative coronary flow reserve
  SPECT = single-photon emission computed tomography


Related Article

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A32. [Full Text] [PDF]






HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2008 by the American College of Cardiology Foundation.